Governance
Investors
  • About us
    • Profile
    • Management
    • Board
    • Scientific Advisory Board
  • Our Science
    • Strategy
    • Enabling Technologies
    • Product Classes
  • Pipeline
    • Pipeline
    • NidlegyTM
    • Fibromun
    • Darleukin
    • Dodekin
    • Dekavil
    • Onco IX
    • OncoFAP Radio Conjugates
    • Tripokin
  • Press Releases & Events
  • Work with us
    • Careers
    • Partnering
  • About us
    • Profile
    • Management
    • Board
    • Scientific Advisory Board
  • Our Science
    • Strategy
    • Enabling Technologies
    • Product Classes
  • Pipeline
    • Pipeline
    • NidlegyTM
    • Fibromun
    • Darleukin
    • Dekavil
    • Dodekin
    • Onco IX
    • OncoFAP Radio Conjugates
    • Tripokin
  • Press Releases & Events
  • Work with us
    • Careers
    • Partnering
  • Investors
    • Investor Relations
    • Shareholding
    • IPO
    • Press Releases
    • Financial Statements
    • Financial Calendar
    • Internal Dealing
    • Buyback
    • Analyst Coverage
    • Webinars
    • IR Contacts
  • Governance
    • Board of Directors
    • Board of Statutory Auditors
    • Documents & Procedures
    • Shareholders’ Meetings
    • Codice etico e Modello 231
    • Sustainability (ESG)

Philogen to attend the 74th Mosbacher Kolloquium in Mosbach/Baden, on March 23-25, 2023

Mar 17, 2023 | 2023, Events, Scientific

Prof. Dr. Dario Neri (CEO and CSO), is giving a presentation on the 23rd of March 2023 entitled “Novel developments on immunocytokines” Follow the link for more details.

Philogen to attend AACR Annual Meeting in Orlando on April 14-18, 2023

Mar 17, 2023 | 2023, Events, Scientific

Prof. Dr. Dario Neri (CEO and CSO), Dr. Covelli (CMO), Dr. Dakhel, Dr. De Luca, Dr. Cazzamalli, Dr. Galbiati, Dr. Puca, Matilde Bocci, Eleonora Prodi, Sara Puglioli, Giulia Rotta and Aureliano Zana will participate at the event. Moreover, the following abstracts have...

Philogen to attend Mid & Small | London 2023 Conference on April 20, 2023

Mar 17, 2023 | 2023, Events

Prof. Dario Neri (CEO and CSO), and Emanuele Puca (Investor Relations) will participate at the event to present Philogen and its programs to the financial community.

Philogen to attend 19th EADO Congress on April 20-22, 2023

Mar 17, 2023 | 2023, Events, Scientific

Dr. Covelli (CMO), Dr. Elia, Dr. Ravenni, and Dr. Nadal will participate at the event in Rome. The dermato-oncology team from St. Gallen will give a presentation entitled “Intralesional administration of L19IL2/L19TNF in difficult-to-treat BCC patients shows favorable...

Philogen to attend the 19th PEGSBOSTON in Boston, on May 15-19, 2023

Mar 17, 2023 | 2023, Events, Scientific

Prof. Dr. Dario Neri (CEO and CSO), is giving a KEYNOTE presentation on the 18th of May 2023 entitled “Antibody-Cytokine Fusions for the Treatment of Difficult-to-Cure Cancer Types: Emerging Clinical Results”. Follow the link for more details.

Philogen to attend the Lund Spring Symposium in Lund on May 22-24, 2023

Mar 17, 2023 | 2023, Events, Scientific

Prof. Dr. Dario Neri (CEO and CSO) is participating as a speaker at Lund Spring Symposium. Follow the link for more details.  
« Older Entries

Recent Posts

  • 20 marzo 2023 – Aggiornamento sul programma di acquisto di azioni proprie
  • Philogen to attend the 74th Mosbacher Kolloquium in Mosbach/Baden, on March 23-25, 2023
  • Philogen to attend AACR Annual Meeting in Orlando on April 14-18, 2023
  • Philogen to attend Mid & Small | London 2023 Conference on April 20, 2023
  • Philogen to attend 19th EADO Congress on April 20-22, 2023

Recent Comments

    Privacy Policy / Cookie Policy

      Contacts

    • Follow
    • Follow

    Philogen S.p.A. ©  Piazza La Lizza, 7 | 53100 Siena (SI) – ITALY | Nr. REA: SI-98772 | P.IVA e CF 00893990523 | Cap. Soc. € 5.731.226,64 i.v. | PEC: AFC@pec.philogengroup.it